Clinical Trial Update: Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating discontinuation and reintroduction of irinotecan for advanced colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Colorectal Neoplasms, Metastases | Phase 2 | Status: TERMINATED